AllianceBernstein

AllianceBernstein Portfolio holdings

AUM $307B
1-Year Return 24.17%
 

AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.

This Quarter Return
+11.6%
1 Year Return
+24.17%
3 Year Return
+108.02%
5 Year Return
+184.14%
10 Year Return
+481.49%
AUM
$282B
AUM Growth
+$29.3B
Cap. Flow
+$4.9B
Cap. Flow %
1.74%
Top 10 Hldgs %
25.02%
Holding
3,412
New
142
Increased
1,243
Reduced
1,421
Closed
126

Sector Composition

1 Technology 24.8%
2 Healthcare 15.7%
3 Consumer Discretionary 12.84%
4 Financials 12.03%
5 Communication Services 9.34%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
EVLO
3201
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$84K ﹤0.01%
695
LCTX icon
3202
Lineage Cell Therapeutics
LCTX
$279M
$83K ﹤0.01%
33,800
ACTG icon
3203
Acacia Research
ACTG
$318M
$81K ﹤0.01%
15,841
ACIC icon
3204
American Coastal Insurance
ACIC
$554M
$80K ﹤0.01%
18,400
VTGN icon
3205
VistaGen Therapeutics
VTGN
$109M
$77K ﹤0.01%
1,320
CCV.WS
3206
DELISTED
Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCV.WS
$76K ﹤0.01%
77,876
EEX icon
3207
Emerald Holding
EEX
$1.02B
$75K ﹤0.01%
18,900
IBIO icon
3208
iBio
IBIO
$16.4M
$75K ﹤0.01%
272
CPUH.WS
3209
DELISTED
Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CPUH.WS
$73K ﹤0.01%
82,785
-30,389
-27% -$26.8K
TNXP icon
3210
Tonix Pharmaceuticals
TNXP
$233M
0
-$122K
AAC.WS
3211
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$72K ﹤0.01%
80,500
BCEL
3212
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$70K ﹤0.01%
23,000
-4,100
-15% -$12.5K
SAND icon
3213
Sandstorm Gold
SAND
$3.37B
$68K ﹤0.01%
10,900
SEEL
3214
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$67K ﹤0.01%
11
SCLEW
3215
DELISTED
Broadscale Acquisition Corp. Warrant
SCLEW
$67K ﹤0.01%
71,441
ARDX icon
3216
Ardelyx
ARDX
$1.57B
$66K ﹤0.01%
59,600
HRTG icon
3217
Heritage Insurance Holdings
HRTG
$747M
$66K ﹤0.01%
11,200
-1,175
-9% -$6.92K
APGB.WS
3218
DELISTED
Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
APGB.WS
$66K ﹤0.01%
69,575
-5,425
-7% -$5.15K
BHIL.WS
3219
DELISTED
Benson Hill, Inc. Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50
BHIL.WS
$64K ﹤0.01%
52,136
ALDX icon
3220
Aldeyra Therapeutics
ALDX
$334M
$61K ﹤0.01%
15,200
SURF
3221
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$60K ﹤0.01%
12,600
SDACW
3222
DELISTED
Sustainable Development Acquisition I Corp. Warrant
SDACW
$60K ﹤0.01%
101,050
APSG.WS
3223
DELISTED
Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer
APSG.WS
$60K ﹤0.01%
46,917
NNBR icon
3224
NN Inc
NNBR
$125M
$56K ﹤0.01%
13,600
BRDS.WS
3225
DELISTED
Bird Global, Inc. Warrants each whole warrant exercisable to purchase 1/25th of a share of Class A Common Stock at an exercise price of $287.50 per share
BRDS.WS
$56K ﹤0.01%
+54,774
New +$56K